Dutasteride suppresses DHT more aggressively than finasteride - by about 90% compared to finasteride's 70%. That difference matters when finasteride has stopped working or was never enough. But it also means the timeline for results, the shedding phase, and the monitoring approach all differ from what finasteride users expect. This guide walks through what the data shows at each phase and how to track your response so you know whether dutasteride is working before your six-month dermatology appointment.
TL;DR
- Dutasteride 0.5 mg daily inhibits both type I and type II 5-alpha reductase, reducing serum DHT by roughly 90%.
- Initial shedding (weeks 4-8) is common and does not signal failure - it reflects the treatment pushing telogen hairs out.
- Most users see stabilization by month 3 and early density improvement by month 6.
- Dutasteride's long half-life (~5 weeks) means levels build gradually and stopping causes a slow washout, not an abrupt loss event.
- 12-week density tracking windows give clinically meaningful data to bring to follow-up appointments.
Important
This article is educational and not medical advice. If you are worried about sudden shedding, scalp symptoms, or side effects, talk to a licensed clinician.
How dutasteride differs from finasteride
Finasteride inhibits only type II 5-alpha reductase, reducing serum DHT by around 70%. Dutasteride inhibits both type I and type II isoforms. Type I is found primarily in the skin and sebaceous glands - including scalp skin. Blocking both pathways achieves roughly 90% DHT suppression in serum and even higher reductions in scalp tissue specifically. This is why dutasteride tends to outperform finasteride in head-to-head clinical trials.
A 2022 systematic review in the Journal of the American Academy of Dermatology found that dutasteride 0.5 mg produced superior hair count and thickness outcomes compared to finasteride 1 mg at 12 and 24 months. The tradeoff is a longer half-life (around 5 weeks vs finasteride's 5-7 hours), which affects how long side effects persist if they occur and how long the drug remains effective after stopping. Read the decision framework for switching from finasteride to dutasteride if you are weighing the options.
Weeks 1-4: the loading phase
DHT suppression begins immediately after the first dose, but serum levels take several weeks to stabilize because of dutasteride's long half-life. By day 14, DHT is typically reduced by over 70%. By week 4, suppression is near its plateau. Most people notice nothing visually during this period - the first month is biochemical, not cosmetic.
If you are switching from finasteride to dutasteride, the transition period involves overlap of both compounds, since finasteride clears within days but dutasteride builds gradually. This overlap is generally benign and does not require a wash-out period. Your clinician may prefer a direct same-day switch or a brief overlap - either approach maintains continuous DHT suppression.
Weeks 4-12: the initial shed
Between weeks 4 and 12, a proportion of dutasteride users experience increased shedding. This is the same mechanism seen with minoxidil: the treatment shifts resting telogen follicles into the active anagen phase, and the existing telogen hairs are pushed out before new growth begins. The shed is diffuse rather than patterned, and it typically resolves by week 12.
This phase is where most people panic and stop treatment - which is the worst time to stop, because the follicle renewal is already in motion. BaldingAI density scores during this period will often show a temporary dip before recovering. Seeing that number move down and then back up in your tracking data is evidence the treatment is working, not failing. For a complete guide to what to log, see dutasteride side effects and what to track.
Months 3-6: stabilization
By month 3, most users see shedding normalize. Hair density typically returns to baseline or slightly above. This is stabilization, not yet significant regrowth - the follicles have stopped miniaturizing further, but thickening takes longer. Clinical trials show that measurable improvements in hair count above baseline begin appearing around months 4-6 with consistent use.
This is also when people make the mistake of stopping because they “do not see enough improvement.” Stabilization at three months is a success signal. Androgenetic alopecia is a progressive condition - stopping progression is exactly the intended outcome, with density improvement as a secondary benefit that develops over a longer horizon.
Months 6-12: density improvement
The largest controlled trial of dutasteride (Gubelin Harcha et al., 2014, JAAD) followed 917 men over 24 weeks. At 24 weeks, dutasteride 0.5 mg produced significantly greater improvements in hair count and global photographic assessment compared to finasteride 1 mg and placebo. Vertex and frontal zones both showed improvement, with the vertex responding faster.
By month 12, most consistent users see their peak response from that first year. Tracking your density scores across 12-week windows will show whether you are in a responder category. A 5-10% density increase over baseline is a meaningful outcome. Flat scores at 12 months while progression is halted is also a win - it means you have preserved what you had.
Year 2 and beyond: maintenance and monitoring
Dutasteride requires continuous use to maintain its effect. Because DHT suppression is ongoing, long-term tolerability matters. Annual PSA monitoring is standard in men over 40, since dutasteride reduces PSA levels by approximately 50% and can mask prostate-specific changes. Inform any physician ordering a PSA that you take dutasteride so they can adjust the reference range accordingly.
If you plan to stop dutasteride at any point, expect a gradual return of DHT over 3-6 months due to the long half-life. Hair loss will resume its pre-treatment trajectory after washout completes. This is different from stopping finasteride, which causes a faster return of DHT and a more abrupt reversal of density gains.
Track your dutasteride response
BaldingAI scores your scalp density weekly so you can see stabilization, the initial shed, and density recovery as objective trends - not guesses.
Your scans stay private. Delete or export anytime.
Common questions
How long does dutasteride take to work?
DHT suppression begins within weeks, but visible hair improvement takes 3-6 months minimum. Meaningful density gains typically appear at 6-12 months with consistent use. Clinical trials use 24-week endpoints as the standard measurement window, and most data shows continued improvement through month 24.
Is shedding on dutasteride normal?
Yes. An initial shedding phase at weeks 4-12 is common and reflects the treatment pushing telogen hairs out as follicles re-enter anagen. This shed is temporary and self-resolving. If shedding persists beyond 16 weeks, or if it is patchy rather than diffuse, consult your prescribing physician to rule out other causes.
Can I take dutasteride every other day?
Because dutasteride has a half-life of approximately 5 weeks, alternate-day dosing does not significantly change serum DHT levels - the compound accumulates regardless of whether you take it daily or every other day at that dosing frequency. Some clinicians prescribe 0.5 mg three times per week for tolerability reasons. Daily dosing is standard and most studied.
Next step
If you are starting dutasteride, take a baseline scan today before your first dose. Photograph your crown from directly above and your temples at 45 degrees. Repeat every four weeks. At 12 weeks, compare your trend to baseline. That data will show you whether you are a responder - and give you something concrete to review with your prescriber at your follow-up.
Sources: Gubelin Harcha et al. (2014) JAAD: Dutasteride vs finasteride in androgenetic alopecia | Huang et al. (2022) JAAD: Systematic review dutasteride for androgenetic alopecia | Eun et al. (2010): Dutasteride 0.5 mg hair density outcomes.
